Introduction {#section0005}
============

The etiologic agent causing severe acute respiratory syndrome (SARS) is a novel coronavirus (CoV) named SARS-CoV ([@bib12], [@bib17], [@bib33], [@bib34], [@bib42], [@bib50], [@bib55]). The disease, which caused an average mortality of approximately 10% and for which no defined therapy is available, was reported for the first time in Guandong province, China, at the end of 2002, and rapidly spread to 32 countries. After July 2003, only four community acquired cases were reported in China, although there have been three instances of laboratory-acquired infections described (<http://www.who.int/csr/sars/en/>).

Initial investigations indicated that SARS-CoV spread to humans from infected wild animals in wet markets of Southern China, such as Himalayan palm civets (*Paguna larvatta*) and Chinese ferret badgers (*Melogale moschatta*) ([@bib23]). Nevertheless, the recognition of SARS-like CoVs in bats suggests that these species are most likely the natural reservoir of SARS-CoV ([@bib38], [@bib41]). Therefore, the reemergence of the virus remains a possibility and the engineering of attenuated viruses as research tools and vaccine candidates is of high interest.

SARS-CoV is an enveloped virus of the *Coronaviridae* family, and has a single-stranded, positive sense 29.7 kb RNA genome ([@bib21], [@bib61]). Human coronaviruses have been divided into different groups ([@bib15]). Group 1 includes the human coronavirus 229E (HCoV-229E), generally associated with the common cold, and HCoV-NL63, which causes more severe lower respiratory diseases ([@bib18], [@bib29], [@bib69]). Group 2 human CoVs include HCoV-OC43, which has been associated with common colds, the recently described HCoV-HKU1, which was identified in adults with pneumonia ([@bib72]), and SARS-CoV. Among human CoVs, SARS-CoV causes the most severe disease ([@bib71]).

Coronaviruses replicate in the cell cytoplasm and encode a nested set of mRNA molecules of different sizes. Viral genome expression begins with the translation of two large polyproteins, pp1a and pp1ab, including the viral replicase genes ([@bib67]). These genes are involved in genome replication and transcription of subgenomic mRNAs (sg mRNAs), encoding structural proteins such as the spike (S), envelope (E), membrane (M), and nucleocapsid (N), and a set of group-specific proteins, whose sequence and number differs among the different species of coronavirus ([@bib15]). In the case of SARS-CoV, open reading frames (ORFs) 3a, 6, 7a, and 7b encode additional structural proteins ([@bib26], [@bib27], [@bib28], [@bib57], [@bib59]).

Genes 3a, 3b, 6, 7a, 7b, 8a, 8b and 9b of SARS-CoV are not found in other CoVs and their functions in the viral cycle are not well understood. Some of these genes are implicated in the pathogenesis of the virus. Genes 6 and 3b inhibit interferon function ([@bib19], [@bib32]). In addition, it has been shown that SARS-CoV gene 6 accelerates murine coronavirus infections ([@bib66]) and enhances virulence of an attenuated murine hepatitis virus (MHV) ([@bib51]). Similarly, it has been shown that the group specific genes of other CoVs contribute to the pathogenesis of the virus *in vivo*, but are not essential for viral replication ([@bib8], [@bib49]). SARS-CoV proteins 3a, 3b, E, M, 7a, and 8a induce apoptosis via several mechanisms ([@bib3], [@bib30], [@bib36], [@bib39], [@bib57], [@bib65], [@bib74]). Furthermore, induction of T-cell apoptosis by E protein may contribute to the lymphopenia that is observed in SARS patients ([@bib74]). Coronavirus proteins M and E are key factors in virus assembly and budding ([@bib4], [@bib5], [@bib6], [@bib7], [@bib16], [@bib35]). In addition, we have shown that deletion of E protein leads to a loss of virulence in hamsters ([@bib9]). Furthermore, SARS-CoV proteins 7a and 9b appear to be associated with intracellular vesicle structures, suggesting a possible role in morphogenesis and replication ([@bib44], [@bib46]).

There is evidence that SARS-CoV group-specific genes can be deleted individually with very limited or no impact on *in vitro* and *in vivo* growth in a murine model ([@bib60], [@bib75]). Some of these genes may have redundant functions, as it has been shown that genes 3b, 6, N, nsp1, and nsp3 may all act as interferon antagonists ([@bib10], [@bib19], [@bib32], [@bib70]). These results prompted us to study the role of E gene in the context of full-length genome or using a virus lacking six accessory genes (6, 7a, 7b, 8a, 8b, and 9b).

SARS-CoV infects and replicates in mice, ferrets, hamsters, cats, and several species of non human primates (cynomolgus and rhesus macaques, African green monkeys, and marmosets) ([@bib63]). Nevertheless, an ideal animal model that completely reproduces human clinical disease and pathological findings is still missing. To overcome these limitations, several approaches have been taken. In one of them, a mouse adapted SARS-CoV was selected and shown to cause an infection that reproduced many aspects of severe SARS ([@bib54]). Interestingly, in other approaches, Tg mice expressing the host receptor for SARS-CoV, hACE-2, have been developed ([@bib43], [@bib68]). These mice are very susceptible to SARS-CoV and are especially useful for pathogenesis studies.

In this paper, the pathogenicity of a collection of SARS-CoV deletion mutants, including those with deletion of the group-specific proteins 6, 7a, 7b, 8a, 8b and 9b, the envelope protein E, or a combination of both, has been evaluated in a Tg mouse in which the expression of hACE-2 was targeted to epithelial cells. The data presented herein show that genes E, 6, 7a, 7b, 8a, 8b, and 9b are not essential for *in vitro* and *in vivo* replication even when all are simultaneously deleted. Interestingly, viruses lacking gene E are attenuated and do not grow in the central nervous system of hACE2 Tg mice, whereas virus lacking genes 6 to 9b, which is not significantly attenuated, grows in the brains of infected mice as well as wt virus. Together, the data indicate that gene E behaves as a virulence factor that contributes to pathogenicity by favoring SARS-CoV replication within specific tissues.

Results {#section0010}
=======

Rescue of rSARS-CoV-Δ\[6--9b\], rSARS-CoV-ΔE, and rSARS-CoV-Δ\[E,6--9b\] viruses {#section0015}
--------------------------------------------------------------------------------

To study the contribution of the group specific genes 6, 7a, 7b, 8a, 8b and 9b, and of the structural gene E to viral pathogenesis in hACE-2 Tg mice, viruses with these genes deleted were constructed using an infectious cDNA clone assembled as a BAC ([@bib2]). To abolish expression of genes 6 to 8b, a deletion comprising nucleotides 27065 to 27977, covering completely ORFs 6, 7a, 7b, 8a, and part of ORF 8b was introduced ([Fig. 1](#fig1){ref-type="fig"} A). To abolish expression of gene 9b, point mutations that abrogated the initiator ATG codon and two in phase downstream ATGs, and one introducing a stop codon were engineered ([Fig. 1](#fig1){ref-type="fig"}A). It was not possible to delete 9b gene, as it totally overlaps with gene N, an essential gene for the virus replication ([@bib1]). Expression of E gene was abolished as previously described ([@bib9]).Fig. 1Rescue of SARS-CoV deletion mutants. Recombinant viruses were rescued by transfecting SARS-CoV cDNA into Vero E6 cells. (A) Genetic organization of the rSARS-CoV-Δ\[6--9b\] virus. The 912-nt deletion that includes ORFs 6, 7a, 7b, 8a, and the 5′ end of ORF 8b is indicated in a light grey box. ORF 9b (darker grey box) was mutated by changes in the ATG codon and in two in phase downstream ATGs and by the introduction of a stop codon (changes are shown in grey and italics). Letters and numbers indicate the viral genes. L, leader sequence; An, polyA tail. The mutations introduced to delete gene E were previously described ([@bib9]). (B) Plaques produced by the indicated viruses on Vero E6 cells.

Infectious viruses were rescued in Vero E6 cells transfected with plasmids pBAC-SARS-CoV-Δ\[6--9b\], pBAC-SARS-CoV-ΔE, pBAC-SARS-CoV-Δ\[E,6--9b\], or pBAC-SARS-CoV^FL^ as a control, indicating that genes E, 6, 7a, 7b, 8a, 8b and 9b are not essential for virus viability. Nevertheless, smaller plaques were detected after infection with rSARS-CoV-ΔE or rSARS-CoV-Δ\[E,6--9b\] viruses but not with rSARS-CoV-Δ\[6--9b\] virus, suggesting that E gene is responsible for this plaque phenotype ([Fig. 1](#fig1){ref-type="fig"}B). The viruses were cloned by three rounds of plaque purification and amplified twice to obtain working viral stocks. The viruses were sequenced to confirm that all point mutations and deletions were maintained.

Growth kinetics of SARS-CoV deletion mutants {#section0020}
--------------------------------------------

To analyze whether the deleted genes affected viral replication, growth kinetics of the defective viruses were determined by infecting different cell lines at a moi of 0.05. Deletion of genes 6 to 9b did not reduce viral titers in monkey Vero E6 cells, whereas a reduction of 20-fold was observed for viruses with E gene deleted (rSARS-CoV-ΔE and rSARS-CoV-Δ\[E,6--9b\]) ([Fig. 2](#fig2){ref-type="fig"} A). Cytopathic effect was detected at 24 h post-infection. Maximal virus titers were detected at 24--48 h post-infection. In human CaCo-2, Huh7.5.1, and Huh-7 cells, titers decreased between 5--10 and 100--1000-fold, for rSARS-CoV-Δ\[6--9b\] and rSARS-CoV-ΔE or rSARS-CoV-Δ\[E,6--9b\], respectively ([Figs. 2](#fig2){ref-type="fig"}B and C, and data not shown). In human cells, no cytopathic effect was observed, and maximal titers were reached at 48--72 h post-infection. Although titers of rSARS-CoV-ΔE or rSARS-CoV-Δ\[E,6--9b\] viruses in CaCo-2 cells are limited, an increase in virus titers of at least 5-fold was observed at 24--48 h post-infection compared to 0 h post-infection, indicating that the viruses replicate in this cell line. The similarity of the growth kinetics exhibited by the ΔE and the Δ\[E,6--9b\] viruses indicated that none of the accessory genes 6, 7a, 7b, 8a, 8b, and 9b complemented any function of E gene required for replication in tissue culture.Fig. 2Growth kinetics of the defective viruses in monkey and human cells. Vero E6 (A), CaCo-2 (B), and Huh7.5.1 cells (C) were infected at a moi of 0.05 with the indicated viruses, and viral titers in cell supernatants at different times post-infection were measured by plaque assay on Vero E6 cells. Error bars represent standard deviations of the mean from three experiments.

Morphogenesis of the defective viruses {#section0025}
--------------------------------------

The effect of deleting E, 6, 7a, 7b, 8a, 8b and 9b genes on viral morphogenesis was examined using electron microscopy. The number of intracellular mature virions present in the cellular cytoplasm was lower in cells infected with viruses lacking E gene than in cells infected with either rSARS-CoV or rSARS-CoV-Δ\[6--9b\] viruses, which is consistent with the lower titers reached by ΔE viruses. Similarly, the number of virions in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) regions where nucleocapsid invagination occurs ([@bib47]), and in intracellular vesicles, where the virus accumulates before budding, was lower in cells infected with ΔE viruses ([Fig. 3](#fig3){ref-type="fig"} C and D) but not with rSARS-CoV or rSARS-CoV-Δ\[6--9b\] ([Fig. 3](#fig3){ref-type="fig"}A and B). Together, these data suggest that the structural E protein influences the efficacy of virus morphogenesis, whereas the other accessory structural proteins 6, 7a, 7b, play a minor role in this process.Fig. 3Ultrastructural analysis of infected Vero E6 cells. Vero E6 cells were infected at a moi of 0.5 with SARS-CoV (A), rSARS-CoV-Δ\[6--9b\] (B), rSARS-CoV-ΔE (C), and rSARS-CoV-Δ\[E,6--9b\] (D). At 24 h post-infection the cells were processed for electron microscopy of ultrathin sections. Mature virus particles (arrows) were detected in ERGIC sites and swollen Golgi sacs that appeared as large vacuoles. Bars, 200 μm.

Extracellular virion morphology observed in infected cells ultrathin sections by electron microscopy ([Fig. 4](#fig4){ref-type="fig"} A) showed the presence of virions with standard spherical morphology in all cases, indicating that the E, 6, 7a, 7b, 8a, 8b and 9b proteins were not essential for final virion morphology. Although the morphology of the ΔE viruses was basically normal, a significant fraction of ellipsoid particles was observed in preparations of rSARS-CoV-Δ\[E,6--9b\] virus, suggesting that the E protein in conjunction with at least one of the other six deleted proteins influences stability or final virion structure. In the two ΔE mutants, a higher accumulation of virions within the budding process was observed in relation to the viruses with E protein ([Fig. 4](#fig4){ref-type="fig"}B). 62.5% of surface-associated ΔE viruses, as compared to only 16.6% of E-containing viruses were captured in the process of budding, strongly suggesting that E protein plays a major role in this process.Fig. 4Morphology of extracellular SARS-CoV deletion mutants. (A) Electron micrographs of ultrathin sections showing extracellular viruses adjacent to the surface of cells infected with the indicated virus. Bars, 200 nm. (B) Ultrathin sections showing the budding process for viruses with (left) and without (right) E protein. Bars, 50 nm.

Negative staining of concentrated virus preparations revealed virions with spherical morphology in all of the mutants, corroborating that none of these proteins were essential to form viral particles with normal morphology. Nevertheless, disrupted particles were more frequently seen in negatively stained ΔE virion preparations than in those of rSARS-CoV-Δ\[6--9b\] virions (data not shown), suggesting that these deletion mutants are more sensitive to mechanical shearing forces.

Pathogenicity of SARS-CoV deletion mutants in Tg mice expressing hACE-2 {#section0030}
-----------------------------------------------------------------------

The pathogenicity of the defective viruses was evaluated in the Tg mice expressing hACE2, which are highly susceptible to SARS-CoV ([@bib43]). Weight loss and mortality of animals intranasally infected with 12,000 pfu were daily evaluated ([Fig. 5](#fig5){ref-type="fig"} ). Mice infected with rSARS-CoV or rSARS-CoV-Δ\[6--9b\] viruses rapidly lost weight, in marked contrast to mice infected with rSARS-CoV-ΔE or rSARS-CoV-Δ\[E,6--9b\] ([Fig. 5](#fig5){ref-type="fig"}A), suggesting that ΔE viruses were attenuated in these mice. Furthermore, all animals infected with rSARS-CoV or rSARS-CoV-Δ\[6--9b\] died by 5 and 6 days post-infection, respectively, whereas those infected with viruses lacking the E gene survived ([Fig. 5](#fig5){ref-type="fig"}B), indicating that the ΔE viruses were fully attenuated even in this highly sensitive animal model.Fig. 5Virulence of the defective viruses. hACE2 Tg mice were intranasally infected with 12,000 pfu (A and B) or with the indicated doses (C and D) of rSARS-CoV, rSARS-CoV-Δ\[6--9b\], rSARS-CoV-ΔE and rSARS-CoV-Δ\[E,6--9b\] viruses. Animals were monitored daily for weight (A) and mortality (B). To further analyze the virulence of rSARS-CoV-Δ\[6--9b\], hACE2 Tg mice were infected with the indicated doses of rSARS-CoV or rSARS-CoV-Δ\[6--9b\] and weight (C) and mortality (D) monitored.

To further analyze rSARS-CoV-Δ\[6--9b\] virulence in hACE-2 Tg mice, a range of virus doses was used to inoculate mice ([Figs. 5](#fig5){ref-type="fig"}C and D) and compared to those infected with wt rSARS-CoV. All mice lost weight and died even at relatively low doses (800 pfu) of wt or rSARS-CoV-Δ\[6--9b\] viruses. Only some mice inoculated with a very low dosage (240 pfu) of either rSARS-CoV-Δ\[6--9b\] or rSARS-CoV, survived. The survival and weight profiles were very similar for mice infected with wild type or rSARS-CoV-Δ\[6--9b\] viruses suggesting that rSARS-CoV-Δ\[6--9b\] was not significantly attenuated in hACE-2 Tg mice.

Virus titers in lung ([Fig. 6](#fig6){ref-type="fig"} A) and brain ([Fig. 6](#fig6){ref-type="fig"}B) of animals infected with 12,000 pfu of the indicated virus mutants were evaluated at 2 and 4 days post-infection. Titers were very high and nearly identical in rSARS-CoV and rSARS-CoV-Δ\[6--9b\]-infected tissues, suggesting that genes 6 to 9b have little effect on viral replication in these animals. In contrast, titers in lungs of mice infected with the ΔE viruses were about 100-fold lower, indicating that this gene is important for efficient *in vivo* virus replication. Interestingly, no infectious virus was detected in the brains of rSARS-CoV-ΔE and rSARS-CoV-Δ\[E,6--9b\]-infected mice ([Fig. 6](#fig6){ref-type="fig"}B), even when the virus was intracranially inoculated (data not shown). In contrast, rSARS-CoV-Δ\[6--9b\] virus was detected at high titers in the brains of infected hACE2 Tg mice suggesting that the E protein is important for virus replication and dissemination within this tissue.Fig. 6In vivo growth kinetics of the variant viruses. hACE2 Tg mice were intranasally inoculated with 12,000 pfu. At 2 and 4 days post-infection, lung (A) and brain (B) tissues were harvested and viral titers were analyzed in Vero E6 cell monolayers. Numbers over bars indicate numbers of mice with detectable virus in relation to the total number of examined mice. Absence of numbers indicate that virus was detected in all examined animals. Black bars, SARS-CoV; gray bars, rSARS-CoV-Δ\[6--9b\], black dashed bars, rSARS-CoV-ΔE, and gray dashed bars, rSARS-CoV-Δ\[E, 6--9b\].

Immunohistochemistry and immunopathology of rSARS-CoV mutants in lungs and brains {#section0035}
---------------------------------------------------------------------------------

Infected lungs and brains (cerebrum) were further analyzed for histological changes and for viral antigen. At day 4 p.i., viral antigen was present in high amounts in the alveoli of mice infected with rSARS-CoV or rSARS-CoV-Δ\[6--9b\], whereas it was detected in low amounts in the alveoli of rSARS-CoV-ΔE or rSARS-CoV-Δ\[E, 6--9b\]-infected mice ([Fig. 7](#fig7){ref-type="fig"} ). Cellular infiltrates were detected in peribronchial regions and in the parenchyma mostly in mice infected with viruses expressing the E protein ([Fig. 7](#fig7){ref-type="fig"}). In contrast, viral antigen was detected throughout the central nervous system (CNS) only in mice infected with rSARS-CoV or rSARS-CoV-Δ\[6--9b\], with prominent infection of the cerebrum, thalamus and brainstem, but not the cerebellum. In the olfactory bulb, only the mitral layer of the olfactory bulb was infected (data not shown). The extent of labeling was nearly the same in mice infected with rSARS-CoV or rSARS-CoV-Δ\[6--9b\]. Consistent with the titer data, no viral antigen was detected in the brains of mice infected with either ΔE virus.Fig. 7Histopathology and immunohistochemistry. hACE2 Tg mice were intranasally inoculated with 12,000 pfu of the indicated viruses and sacrificed at day 4 p.i. Zinc formalin-fixed lungs (left) and brain (cerebrum) (right) were analyzed for viral antigen as described in [Materials and methods](#sec9){ref-type="sec"}. Original magnification was 10×.

Discussion {#section0040}
==========

Our results show that neither the E protein nor several SARS-CoV accessory proteins (6a, 7a, 7b, 8a, 8b, and 9b) are required for virus replication *in vitro* or in hACE2 Tg mice. Growth kinetics assays in monkey and human cell lines, studies of morphogenesis by electron microscopy, and analyses in the Tg mice all suggest that SARS-CoV E gene is a virulence factor.

Interestingly, rSARS-CoV-Δ\[6--9b\] virus, in which six genes were deleted, grew as well as the wt virus in monkey Vero E6 cells whereas mutants in which E gene was deleted (rSARS-CoV-ΔE, and rSARS-CoV-Δ\[E,6--9b\]) showed a 20-fold titer reduction. In human cells, titers of rSARS-CoV lacking either 6--9b or E genes were reduced up to 10- or 1000-fold, respectively, suggesting that gene E is relevant for viral replication as previously described ([@bib9]), and that genes 6 to 9b have a significant, although very limited influence on viral replication at least in some cell systems. The reduced growth of the wt and the three deletion mutants in human as opposed to Vero E6 cells, could be due to the absence of type 1 interferon expression in the latter ([@bib13]).

The hACE-2 Tg mice is a suitable animal model to evaluate the virulence of the defective viruses, as it has been shown that all the animals died even when infected with low doses of wt SARS-CoV. Using highly susceptible hACE-2 Tg mice, we found, surprisingly, that virus titers of wt virus and rSARS-CoV-Δ\[6--9b\], were similar in both the lung and brain. Furthermore, weight loss and survival curves were also similar, indicating that rSARS-CoV-Δ\[6--9b\] is not significantly attenuated in these mice. The virulence of the Δ\[6--9b\] deletion mutant came as a surprise as in the *Coronaviridae*, the functions of the group specific ORFs are generally associated with counteracting host defenses. In fact, recombinant MHV, feline infectious peritonitis virus (FIPV) and transmissible gastroenteritis virus (TGEV) lacking one or more of these group specific ORFs efficiently replicate in cell culture but are attenuated *in vivo* ([@bib8], [@bib24], [@bib49]). On the other hand, the virulence of rSARS-CoV-Δ\[6--9b\] virus is in agreement with previous results showing that recombinant SARS-CoVs individually lacking each of the group specific genes 3a, 3b, 6, 7a, and 7b were not significantly impaired in replication *in vitro* or in non-transgenic Balb/c mice ([@bib60], [@bib75]). Similarly, in the MHV system, it has been shown that deletion of ORF 4 in MHV does not affect virulence ([@bib48]).

Titers of E protein deletion mutants (rSARS-CoV-ΔE and rSARS-CoV-Δ\[E,6--9b\]) in the lungs of hACE2 Tg mice were about 100-fold lower than in mice infected with wt virus or virus lacking genes 6 to 9b. The observed reduction in virus titers probably is only partially responsible for the attenuated phenotype of the ΔE viruses, as we showed that viruses lacking E gene did not spread to the central nervous system, even when the virus was intracranially inoculated (data not shown). These data suggest that gene E is important for virus tissue tropism. Changes in virus tissue tropism frequently are an important cause of virus attenuation as shown for other coronaviruses such as TGEV, in which loss of virulence is associated with loss of enteric tropism ([@bib56]). Similarly, live poliovirus vaccines are attenuated because of their reduced neurotropism with a concomitant increase in enteric growth ([@bib64]). It is likely that the infection of the central nervous system is a major factor contributing to the fatal outcome observed for SARS-CoV-infected Tg mice ([@bib43], [@bib68]). While the brain is not considered a major target for the virus in humans, there are reports showing the presence of the virus in this tissue ([@bib11], [@bib22], [@bib73]). Further, some SARS survivors have neurological and psychological sequelae that are not well understood and could result from infection of the central nervous system ([@bib40], [@bib73]). The molecular mechanism involved in the attenuation and changes in tropism of E protein deletion mutants is under further investigation and might suggest new biological functions for the E protein.

SARS-CoV lacking E gene is attenuated in the highly sensitive hACE-2 Tg mice model and in hamsters ([@bib9], [@bib14]) suggesting that SARS-CoV mutants defective in E gene may also be attenuated in other species including humans. Accordingly, the induction of protection conferred by these viruses has been studied in hamsters showing complete protection. Therefore, these deletion mutants could be considered promising vaccine candidates. Nevertheless, more detailed experiments in this and other animal models, including non-human primates, are needed in order to further evaluate the safety and efficacy of these attenuated viruses as vaccine candidates. Another application of these genetically attenuated viruses of practical interest is their use as the starting material for the generation of chemically inactivated vaccines. Thus, in the event of incomplete chemical inactivation of the vaccine virus, the remaining infectious virus will be highly attenuated, reducing the likelihood of untoward consequences ([@bib31], [@bib52], [@bib53], [@bib62], [@bib77]).

Materials and methods {#sec9}
=====================

Cells {#section0045}
-----

African Green monkey kidney-derived Vero E6 cells, human liver-derived Huh-7 cells, human colon carcinoma-derived CaCo-2 cells, and the Huh7.5.1 clone derived from Huh-7 cells ([@bib20], [@bib25], [@bib45], [@bib76]) were kindly provided by E. Snijder (University of Leiden, The Netherlands), R. Bartenschlager (University of Heidelberg, Germany), the European Collection of Cell Cultures and F. V. Chisari (Scripps Research Institute, La Jolla, California), respectively. In all cases, cells were grown in Dulbecco\'s modified Eagle\'s medium (DMEM, GIBCO, Grand Island, NY) supplemented with 25 mM HEPES and 10% fetal bovine serum (FBS) (Biowhittaker, Verviers, Belgium). Virus titrations were performed in Vero E6 cells following standard procedures using closed flasks or plates sealed in plastic bags. For plaque assays, cells were fixed with 10% formaldehyde and stained with crystal violet three days post-infection. All work with infectious viruses and infected animals was performed in biosafety level (BSL) 3 facilities by personnel wearing positive-pressure air purifying respirators (3 M HEPA AirMate, Saint Paul, MN).

Mice {#section0050}
----

hACE2 Tg mice were generated as previously described and were used after backcrossing 6--9 generations to C57Bl/6 mice ([@bib43]). No differences were observed in disease or histological outcome when mice that were backcrossed to different extents were compared. All animal experiments were approved by the University of Iowa Animal Use and Care Committee.

Construction of plasmids pBAC-SARS-CoV-Δ\[6--9b\], pBAC-SARS-CoV-ΔE, and pBAC-SARS-CoV-Δ\[E, 6--9b\] {#section0055}
----------------------------------------------------------------------------------------------------

The pBAC-SARS-CoV-Δ\[6--9b\] plasmid encoding a rSARS-CoV lacking accessory genes 6, 7a, 7b, 8a, 8b and 9b was constructed using a previously described full-length infectious cDNA clone coding for SARS-CoV, Urbani strain in a bacterial artificial chromosome (BAC) (plasmid pBAC-SARS-CoV^FL^) ([@bib2]). The pBAC-SARS-CoV-ΔE plasmid encoding a rSARS-CoV lacking the gene E was constructed from plasmid pBAC-SARS-CoV^FL^ as described ([@bib9]). The pBAC-SARS-CoV-Δ\[E,6--9b\] plasmid encoding a rSARS-CoV lacking the E, 6, 7a, 7b, 8a, 8b and 9b genes was constructed from plasmid pBAC-SARS-CoV-ΔE. To generate plasmids pBAC-SARS-CoV-Δ\[6--9b\] and pBAC-SARS-CoV-Δ\[E,6--9b\], deletion of genes 6, 7a, 7b, 8a and 8b was introduced by overlap extension PCR using as templates the plasmids pBAC-SARS-CoV^FL^ and pBAC-SARS-CoV-ΔE, respectively. The final PCR products were digested with the enzymes BamHI and NheI and cloned in the intermediate plasmid psl1190+BamHI/SacII SARS-CoV to generate the plasmids psl1190+BamHI/SacII SARS-CoV-Δ\[6,7,8\] and psl1190+BamHI/SacII SARS-CoV-Δ\[E,6,7,8\]. The plasmid psl1190+BamHI/SacII SARS-CoV contains a fragment corresponding to nucleotides 26045 to 30091 of the SARS-CoV infectious cDNA clone ([@bib2]) engineered into plasmid psl1190 (Pharmacia) using the unique restriction sites BamHI and SacII. To abrogate expression of gene 9b, overlap PCR extension was performed using as template the infectious cDNA clone ([@bib2]). The final PCR product was digested with the enzymes KpnI and NheI and cloned into plasmids psl1190+BamHI/SacII SARS-CoV-Δ\[6,7,8\] and psl1190+BamHI/SacII SARS-CoV-Δ\[E,6,7,8\], to assemble plasmids psl1190+BamHI/SacII SARS-CoV-Δ\[6--9b\] and psl1190+BamHI/SacII SARS-CoV-Δ\[E,6--9b\]. Finally, fragment BamHI/SacII of these plasmids was exchanged with that of plasmid pBAC-SARS-CoV^FL^ to generate plasmids pBAC-SARS-CoV-Δ\[6--9b\] and pBAC-SARS-CoV-Δ\[E,6--9b\]. Details on the cloning can be obtained from the authors upon request.

Transfection and recovery of infectious viruses from the cDNA clones {#section0060}
--------------------------------------------------------------------

BHK cells grown to 90% confluence in 12.5 cm^2^ flasks were transfected with 6 μg of the plasmids pBAC-SARS-CoV-Δ\[6--9b\], pBAC-SARS-CoV-ΔE, and pBAC-SARS-CoV-Δ\[E,6--9b\], or the plasmid pBAC-SARS-CoV^FL^ as a control, using 18 μg of Lipofectamine 2000 (Invitrogen) according to manufacturer\'s instructions. Recombinant viruses were cloned as described ([@bib9]).

rSARS-CoV-Δ\[6--9b\], rSARS-CoV-ΔE, and rSARS-CoV-Δ\[E,6--9b\] growth kinetics {#section0065}
------------------------------------------------------------------------------

Subconfluent monolayers (90% confluency) of Vero E6, Huh-7, Huh-7.5.1 and CaCo-2 cells were inoculated at a multiplicity of infection (moi) of 0.05 with the viruses rSARS-CoV, rSARS-CoV-Δ\[6--9b\], rSARS-CoV-ΔE, and rSARS-CoV-Δ\[E,6--9b\]. After an absorption period of 1 h, inoculum medium was removed and fresh medium added. Then, culture supernatants were collected at different times post-infection and virus titers were determined as described above.

RNA analysis by RT-PCR {#section0070}
----------------------

Total RNA from Vero E6-infected cells was purified using the QIAGEN RNeasy kit according to the manufacturer\'s instructions and used for reverse transcription (RT)-PCR analysis. The regions comprising gene E and genes 6 to 9b were analyzed. RT reactions were performed using murine leukemia virus reverse transcriptase (Ambion) and the reverse primers SARS-E231-RS (5′-TTAGACCAGAAGATCAGGAACTCC-3-), complementary to nt 208 to 231 of E gene, to analyze gene E deletion and mutations, and SARS-28397-RS (5′-GGGTAGCTCTTCGGTAGTAGCC-3′), complementary to nucleotides 28376 to 28397 of the SARS-CoV genome, to analyze deletion of genes 6 to 8b and 9b mutations. The cDNAs were amplified by PCR using sense primers SARS-25211-VS (5′-GGATGACTCTGAGCCAGTTCTCAAGGG-3′), complementary to nucleotides 25212 to 25238 of SARS-CoV genome and SARS-27024-VS (5′-CGCCGGTAGCAACGACAATATTGC-3′), complementary to nucleotides 27025 to 27048, and the reverse primers indicated above. RT-PCR products were visualized by electrophoresis in 0.8% agarose gels and sequenced using the primers used for the RT-PCR reactions.

Electron microscopy {#section0075}
-------------------

For conventional electron microscopy, Vero E6 cell monolayers were infected with rSARS-CoV, rSARS-CoV-Δ\[6--9b\], rSARS-CoV-ΔE, and rSARS-CoV-Δ\[E,6--9b\] at a moi of 0.5. Cells were fixed *in situ* 20 h post-infection with 2% glutaraldehyde in phosphate Na/K buffer (pH 7.4) for 1 h at room temperature. Cells were removed and transferred to Eppendorf tubes. After centrifugation, cells were washed three times in phosphate Na/K buffer (pH 7.4) and processed for embedding in Epoxy, TAAB 812 resin (TAAB Laboratories, Berkshire, England) according to standard procedures ([@bib9]). Ultrathin sections of the samples were stained with saturated uranyl acetate and lead citrate and examined at 80 kV in a Jeol JEM-1010 (Tokyo, Japan) electron microscope.

For negative staining electron-microscopy, supernatants of Vero E6 cells infected for 20 h were fixed with 10% formaldehyde, concentrated using a Beckman airfuge, negatively stained and examined by electron microscopy as described ([@bib9]).

Virus replication in Tg mice expressing hACE-2 {#section0080}
----------------------------------------------

Mice were lightly anesthetized with isoflurane and inoculated intranasally with the indicated doses of virus in 30 μl of DMEM. Infected mice were examined and weighted daily. In parallel experiments, to obtain tissues for virus titrations, animals were sacrificed at 2 and 4 days post-infection and lungs and brains were aseptically removed into phosphate buffered saline (PBS). Tissues were homogenized using a manual homogenizer, and titrated in Vero E6 cells as described above. Virus titers are expressed as pfu/g tissue with a lower limit of detection of 420 pfu/g.

Histopathological examination of brains and lungs of infected mice {#section0085}
------------------------------------------------------------------

Brains (cerebrum) and lungs were removed from mice at 4 days p.i., fixed in zinc formalin and processed as described previously ([@bib43]). For routine histology, sections were stained with hematoxylin and eosin. To detect virus antigen, cells were pretreated with 3% hydrogen peroxide and stained with biotinylated mouse anti-nucleocapsid mAb (kindly provided by Dr. John Nicholls, University of Hong Kong), followed by streptavidin-HRP (Jackson Immunoresearch, West Grove, PA). Slides were developed with diaminobenzidine and counterstained with nuclear fast red (lungs) or hematoxylin (brains).
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